Compare SIF & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SIF | CSBR |
|---|---|---|
| Founded | 1913 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.2M | 82.7M |
| IPO Year | 1995 | 2015 |
| Metric | SIF | CSBR |
|---|---|---|
| Price | $13.27 | $5.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 156.2K | 5.9K |
| Earning Date | 05-27-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 86.67 | ★ 161.11 |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $111,212,000.00 | $2,900,000.00 |
| Revenue This Year | N/A | $4.84 |
| Revenue Next Year | N/A | $11.51 |
| P/E Ratio | $44.14 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.33 | $5.59 |
| 52 Week High | $15.00 | $10.25 |
| Indicator | SIF | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 62.37 | 43.99 |
| Support Level | $5.92 | $5.59 |
| Resistance Level | N/A | $6.96 |
| Average True Range (ATR) | 1.38 | 0.17 |
| MACD | -0.13 | 0.02 |
| Stochastic Oscillator | 65.25 | 46.23 |
SIFCO Industries Inc produces forgings, sub-assemblies, and machined components for the Aerospace and Energy markets. Its services include forging, heat treating, machining, surface treatment, non-destructive testing, and sub-assembly of forged components. The company manufactures envelopes and precision forgings, as well as rough and finished machined parts, serving OEMs, Tier 1 and Tier 2 suppliers, and aftermarket providers across Aerospace, Defense, Energy, and Commercial Space. Its Products are made from steel, high-temperature alloys, nickel alloys, titanium, and aluminum, and include components for aircraft and industrial gas turbine engines, airframe structures, landing gear, wheels and brakes, helicopter rotating parts, and other commercial and industrial applications.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.